Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC DGY-06-116 | 2556836-50-9 | 99.5% | C32H33ClN8O2 | 10MG
SDP

Catalog No. 5000261237
Encompass_Preferred

DGY-06-116 is an irreversible covalent Src kinase inhibitor with potent biochemical activity (IC50 3 nM) and limited activity against FGFR1 (IC50 ~8,340 nM). It is supplied as a high-purity solid and is available as a ready-to-use DMSO solution or multiple milligram pack sizes for preclinical research.

  • Irreversible covalent Src inhibitor with IC50 3 nM.
  • Low activity against FGFR1 (IC50 ~8,340 nM).
  • High purity (99.54%).
  • Supplied as a white to off-white solid.
  • Soluble in DMSO (250 mg/mL) and compatible with in vivo formulations.
  • Stable as powder at -20°C and in solvent at -80°C.
  • Available in multiple pack sizes and as a 10 mM DMSO solution.

Catalog No. 50-002-61237 Supplier Medchemexpress LLC Supplier No. HY13660510MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DGY-06-116 is an irreversible covalent Src kinase inhibitor with potent biochemical activity (IC50 3 nM) and limited activity against FGFR1 (IC50 ~8,340 nM). It is supplied as a high-purity solid and is available as a ready-to-use DMSO solution or multiple milligram pack sizes for preclinical research.

  • Irreversible covalent Src inhibitor with IC50 3 nM.
  • Low activity against FGFR1 (IC50 ~8,340 nM).
  • High purity (99.54%).
  • Supplied as a white to off-white solid.
  • Soluble in DMSO (250 mg/mL) and compatible with in vivo formulations.
  • Stable as powder at -20°C and in solvent at -80°C.
  • Available in multiple pack sizes and as a 10 mM DMSO solution.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.